NCT05987917View on ClinicalTrials.gov

Clinical and Histological Evaluation of BTL-785F Non-invasive Treatment for Facial Rejuvenation

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

January 25, 2021

Primary Completion Date

January 3, 2022

Study Completion Date

January 3, 2022

Conditions
Wrinkle
Interventions
DEVICE

BTL-785-2

Treatment with BTL-785 device (BTL-785-2 applicator) for non-invasive facial rejuvenation

OTHER

No Treatment

The subject who will serve as control will not be treated with the study device.

Trial Locations (1)

07601

Schweiger Dermatology PC, Reseach Division, Hackensack

All Listed Sponsors
lead

BTL Industries Ltd.

INDUSTRY

NCT05987917 - Clinical and Histological Evaluation of BTL-785F Non-invasive Treatment for Facial Rejuvenation | Biotech Hunter | Biotech Hunter